Mercer Global Advisors
RCEL icon

Mercer Global Advisors’s Avita Medical RCEL Stock Holding History

Mercer Global Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.1K Buy
+11,640
New +$50.2K ﹤0.01% 4331

Other funds holding RCEL

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Mercer Global Advisors's RCEL Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Avita Medical (RCEL) in Q2 2026: 11,640 shares worth $48.1K. The stake represents ﹤0.01% of the portfolio and ranks #4331 among its holdings.

68 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Mercer Global Advisors held 11,640 shares of Avita Medical worth $48.1K as of Q2 2026.
  • Avita Medical was a new Mercer Global Advisors position in Q2 2026.
  • Avita Medical made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4331 holding.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.